Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Change in Cash (2024 - 2025)

Historic Change in Cash for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to -$2.8 million.

  • Connect Biopharma Holdings' Change in Cash rose 7796.32% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.3 million, marking a year-over-year change of. This contributed to the annual value of -$27.4 million for FY2024, which is 20267.63% down from last year.
  • Per Connect Biopharma Holdings' latest filing, its Change in Cash stood at -$2.8 million for Q3 2025, which was up 7796.32% from -$7.1 million recorded in Q2 2025.
  • In the past 5 years, Connect Biopharma Holdings' Change in Cash ranged from a high of $8.4 million in Q1 2024 and a low of -$30.5 million during Q1 2025